John,
Sorry to hear you don't currently have a position, it seems you've missed a good runup. I believe this is just the beginning, especially if more good data is forthcoming.
I hope you're considering getting back in, the chat over on RB is that 25 to 30 cents is very possible in the next few weeks. I'm sure hoping they're right, but I really believe GMED could be worth far more than that if the good Doctor's treatments work as well as they seem to be.
I know nothing about how he's used patents to protect his applications, but as I see it, if he's right the developer of the drug should willingly partner with GMED rather then fighting them, where they could potentially lose tens or hundreds of millions.
I've seen penny stocks reach double digits in a matter of months before. If GMED can help to cure patients who acquire some of the new, exotic viruses, like SARS, I have few doubts that GMED will be a huge success story. I was also impressed by a poster on RB who's being treated by GMED, I believe it was for kidney disease, she indicated the disease was not progressing, and she's now an investor in the company.
I hope you stay active on the board, and invest again as you choose. GMED is a small investment for me, my primary investment is in IMGN, but with a little luck GMED could become a major part of my portfolio. I certainly like everything I'm hearing about it for now.
Gary |
